PURE Bioscience (PURE) SEC Filings & 10K Form $0.09 +0.01 (+11.84%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Recent PURE Bioscience SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView12/16/20243:20 PMPURE Bioscience (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/16/20243:25 PMPURE Bioscience (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 12/12/20243:30 PMPURE Bioscience (Filer)Form DEF 14A10/29/20244:12 PMPURE Bioscience (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/29/20244:23 PMPURE Bioscience (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 09/20/20243:45 PMPURE Bioscience (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/22/20244:54 PMPURE Bioscience (Issuer)Zehr Darin (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/22/20244:56 PMChen Ivan (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/22/20244:58 PMBARTLETT ROBERT F (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/22/20245:00 PMLee Tom Y (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/22/20245:02 PMElliott Mark Stuart (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/22/20245:04 PMBlotner Bernard (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/22/20245:05 PMPURE Bioscience (Issuer)Rendall David (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/22/20245:06 PMMyers Thomas Richard (Reporting)PURE Bioscience (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/13/20245:16 PMPURE Bioscience (Issuer)Zehr Darin (Reporting)Form 3Initial statement of beneficial ownership of securities 05/07/20244:00 PMPURE Bioscience (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/10/20243:30 PMPURE Bioscience (Filer)Form DEF 14A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies EVGN SEC Filings GURE SEC Filings SUIC SEC Filings SNES SEC Filings NITO SEC Filings CNEY SEC Filings HGYN SEC Filings MACE SEC Filings AEPT SEC Filings TANH SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:PURE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
